YSPSAH Stock Overview
Manufactures and trades in generic drugs. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
My Notes
Capture your thoughts, links and company narrative
Y.S.P. Southeast Asia Holding Berhad Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | RM 2.30 |
| 52 Week High | RM 3.18 |
| 52 Week Low | RM 2.20 |
| Beta | 0.23 |
| 1 Month Change | 1.32% |
| 3 Month Change | -4.96% |
| 1 Year Change | -0.43% |
| 3 Year Change | 19.17% |
| 5 Year Change | -1.29% |
| Change since IPO | 28.36% |
Recent News & Updates
Recent updates
Y.S.P. Southeast Asia Holding Berhad (KLSE:YSPSAH) Seems To Use Debt Quite Sensibly
Aug 21
Y.S.P. Southeast Asia Holding Berhad's (KLSE:YSPSAH) Dividend Will Be Increased To MYR0.11
Apr 26Estimating The Intrinsic Value Of Y.S.P. Southeast Asia Holding Berhad (KLSE:YSPSAH)
Mar 03We Think You Can Look Beyond Y.S.P. Southeast Asia Holding Berhad's (KLSE:YSPSAH) Lackluster Earnings
Mar 04Y.S.P. Southeast Asia Holding Berhad (KLSE:YSPSAH) Seems To Use Debt Quite Sensibly
Sep 01Should Y.S.P. Southeast Asia Holding Berhad (KLSE:YSPSAH) Be Part Of Your Dividend Portfolio?
Mar 31Y.S.P. Southeast Asia Holding Berhad's (KLSE:YSPSAH) Shareholders Are Down 15% On Their Shares
Mar 10Is Y.S.P. Southeast Asia Holding Berhad's (KLSE:YSPSAH) Recent Price Movement Underpinned By Its Weak Fundamentals?
Feb 11Is Y.S.P. Southeast Asia Holding Berhad (KLSE:YSPSAH) A Risky Investment?
Jan 21Is Y.S.P. Southeast Asia Holding Berhad (KLSE:YSPSAH) An Attractive Dividend Stock?
Dec 30Y.S.P. Southeast Asia Holding Berhad's(KLSE:YSPSAH) Share Price Is Down 11% Over The Past Three Years.
Dec 09
Shareholder Returns
| YSPSAH | MY Pharmaceuticals | MY Market | |
|---|---|---|---|
| 7D | 0% | -0.8% | -0.7% |
| 1Y | -0.4% | -2.3% | 10.2% |
Return vs Industry: YSPSAH exceeded the MY Pharmaceuticals industry which returned -2.3% over the past year.
Return vs Market: YSPSAH underperformed the MY Market which returned 10.2% over the past year.
Price Volatility
| YSPSAH volatility | |
|---|---|
| YSPSAH Average Weekly Movement | 3.4% |
| Pharmaceuticals Industry Average Movement | 3.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in MY Market | 10.5% |
| 10% least volatile stocks in MY Market | 2.5% |
Stable Share Price: YSPSAH has not had significant price volatility in the past 3 months compared to the MY market.
Volatility Over Time: YSPSAH's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 1,362 | Fang-Hsin Lee | www.yspsah.com |
Y.S.P. Southeast Asia Holding Berhad, together with its subsidiaries, manufactures and trades in generic drugs. The company operates through three segments: Manufacturing, Trading, and Investment Holding. It manufactures, sells, imports, exports, trades in, and distributes pharmaceutical and veterinary products, pharmaceutical fine chemicals, raw material, health food products, and medical devices.
Y.S.P. Southeast Asia Holding Berhad Fundamentals Summary
| YSPSAH fundamental statistics | |
|---|---|
| Market cap | RM 326.24m |
| Earnings (TTM) | RM 28.65m |
| Revenue (TTM) | RM 361.24m |
11.4x
P/E Ratio0.9x
P/S RatioIs YSPSAH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| YSPSAH income statement (TTM) | |
|---|---|
| Revenue | RM 361.24m |
| Cost of Revenue | RM 203.30m |
| Gross Profit | RM 157.94m |
| Other Expenses | RM 129.29m |
| Earnings | RM 28.65m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.20 |
| Gross Margin | 43.72% |
| Net Profit Margin | 7.93% |
| Debt/Equity Ratio | 9.2% |
How did YSPSAH perform over the long term?
See historical performance and comparisonDividends
4.8%
Current Dividend Yield40%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 21:23 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Y.S.P. Southeast Asia Holding Berhad is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yi Jing Chua | Affin Hwang Investment Bank |
| Lik Hsin Aw | CGS International |
| Bei Shan Ng | MIDF Research |